Greg Brophy Email & Phone Number

NKore is a cellular-based biotherapeutics business focused on the diagnosis and treatment of cancer. NKore's IP portfolio includes a robust diagnostic platform to measure the cellular function of the immune system and a proprietary approach to activating or "supercharging" the immune system to deliver more effective, less toxic treatment options for cancer.

Alafair is a commercial stage biotechnology company that has developed and commercialized a platform of novel biologic products based on its patented non-cell adhesive hydrogel technology primarily used in orthopedic and spine procedures.

Biologics was sold to a public company in August 2016. Prior to its sale, the company was engaged in the commercialization of human tissue and cellular-based products for the regenerative medicine market. The company's research and development focused on the regenerative potential of the placental tissues given their rich source of undifferentiated stem.

US

The Diagnostic Division was sold to a private equity group in July 2007. Prior to its sale, the Division was the fifth largest provider of independent outpatient diagnostic imaging services in the country with 83 facilities in 27 States.

CTI was sold to Siemens, A.G. in May 2005. Prior to its sale, CTI was the industry leader in positron emission tomography (PET), a medical imaging device principally used in the detection of cancer. The Clinical Tomograph Business Group was responsible for the manufacture, development and field service of the PET and PET/CT tomographs with annual sales of.

Atlanta, GA, US

Corporate finance partner focusing on merger & acquisitions, public and private equity offerings, venture capital financing and the formation of strategic alliances for technology and health care companies.

Master Of Business Administration (M.B.A.), Business Administration, Management And Operations

Juris Doctor (J.D.), Law

B.S., Electrical Engineering